| __timestamp | HUTCHMED (China) Limited | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 91813000 | 28203205 |
| Thursday, January 1, 2015 | 178203000 | 99892000 |
| Friday, January 1, 2016 | 216080000 | 133591000 |
| Sunday, January 1, 2017 | 241203000 | 154937000 |
| Monday, January 1, 2018 | 214109000 | 164246000 |
| Tuesday, January 1, 2019 | 204890000 | 175338000 |
| Wednesday, January 1, 2020 | 227976000 | 198321000 |
| Friday, January 1, 2021 | 356128000 | 227490000 |
| Saturday, January 1, 2022 | 426409000 | 212018000 |
| Sunday, January 1, 2023 | 837999000 | 145238000 |
Unleashing the power of data
In the dynamic world of pharmaceuticals, revenue generation is a key indicator of a company's market position and growth potential. Over the past decade, HUTCHMED (China) Limited and Travere Therapeutics, Inc. have been pivotal players in this arena. From 2014 to 2023, HUTCHMED consistently outperformed Travere in revenue generation, with a notable surge in 2023, where it nearly quadrupled its revenue compared to 2014. This represents a staggering 813% increase over the period. In contrast, Travere Therapeutics saw a more modest growth, with its revenue increasing by approximately 415% during the same timeframe. The data highlights HUTCHMED's strategic advancements and market expansion, particularly in recent years. As the pharmaceutical industry continues to evolve, these companies' financial trajectories offer valuable insights into their competitive strategies and future potential.
AbbVie Inc. and HUTCHMED (China) Limited: A Comprehensive Revenue Analysis
Comparing Revenue Performance: Takeda Pharmaceutical Company Limited or HUTCHMED (China) Limited?
Annual Revenue Comparison: Takeda Pharmaceutical Company Limited vs Travere Therapeutics, Inc.
Ascendis Pharma A/S vs Travere Therapeutics, Inc.: Examining Key Revenue Metrics
Jazz Pharmaceuticals plc and HUTCHMED (China) Limited: A Comprehensive Revenue Analysis
Lantheus Holdings, Inc. or HUTCHMED (China) Limited: Who Leads in Yearly Revenue?
Revenue Insights: Lantheus Holdings, Inc. and Travere Therapeutics, Inc. Performance Compared
Revenue Showdown: Perrigo Company plc vs Travere Therapeutics, Inc.
MorphoSys AG vs Travere Therapeutics, Inc.: Annual Revenue Growth Compared
Vericel Corporation and Travere Therapeutics, Inc.: A Comprehensive Revenue Analysis
Supernus Pharmaceuticals, Inc. or Travere Therapeutics, Inc.: Who Leads in Yearly Revenue?
Breaking Down Revenue Trends: Geron Corporation vs Travere Therapeutics, Inc.